| Prospective evaluation of hematocrit in gender‐affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence J Defreyne, B Vantomme, E Van Caenegem, K Wierckx, CJM De Blok, ... Andrology 6 (3), 446-454, 2018 | 104 | 2018 |
| Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen DM Van Velzen, A Paldino, M Klaver, NM Nota, J Defreyne, GK Hovingh, ... The Journal of Clinical Endocrinology & Metabolism 104 (6), 1937-1947, 2019 | 97 | 2019 |
| Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons J Defreyne, LDL Van de Bruaene, E Rietzschel, J Van Schuylenbergh, ... Clinical Chemistry 65 (1), 119-134, 2019 | 82 | 2019 |
| Effects of sex hormone treatment on the metabolic syndrome in transgender individuals: focus on metabolic cytokines MK Auer, T Ebert, M Pietzner, J Defreyne, J Fuss, GK Stalla, G T’Sjoen The Journal of Clinical Endocrinology & Metabolism 103 (2), 790-802, 2018 | 77 | 2018 |
| Self‐perception of voice in transgender persons during cross‐sex hormone therapy C Bultynck, C Pas, J Defreyne, M Cosyns, M den Heijer, G T'Sjoen The Laryngoscope 127 (12), 2796-2804, 2017 | 77 | 2017 |
| Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people S Shadid, K Abosi-Appeadu, AS De Maertelaere, J Defreyne, L Veldeman, ... Diabetes Care 43 (2), 411-417, 2020 | 67 | 2020 |
| Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment J Defreyne, N Nota, C Pereira, T Schreiner, AD Fisher, M Den Heijer, ... LGBT health 4 (5), 328-336, 2017 | 65 | 2017 |
| Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review J Defreyne, J Motmans, G T’sjoen Expert Review of Pharmacoeconomics & Outcomes Research 17 (6), 543-556, 2017 | 56 | 2017 |
| Sexual desire changes in transgender individuals upon initiation of hormone treatment: results from the longitudinal European network for the investigation of gender incongruence J Defreyne, E Elaut, B Kreukels, AD Fisher, G Castellini, A Staphorsius, ... The Journal of Sexual Medicine 17 (4), 812-825, 2020 | 50 | 2020 |
| Health considerations for transgender women and remaining unknowns: a narrative review SJ Iwamoto, J Defreyne, MS Rothman, J Van Schuylenbergh, ... Therapeutic advances in endocrinology and metabolism 10, 2042018819871166, 2019 | 48 | 2019 |
| Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI) J Defreyne, Y Vanwonterghem, S Collet, SJ Iwamoto, CM Wiepjes, ... International journal of transgender health 21 (2), 163-175, 2020 | 47 | 2020 |
| Parental desire and fertility preservation in assigned female at birth transgender people living in Belgium J Defreyne, J Van Schuylenbergh, J Motmans, KL Tilleman, GGR T’Sjoen Fertility and Sterility 113 (1), 149-157. e2, 2020 | 45 | 2020 |
| Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy M Klaver, D van Velzen, C de Blok, N Nota, C Wiepjes, J Defreyne, ... The Journal of Clinical Endocrinology & Metabolism 107 (1), e153-e164, 2022 | 41 | 2022 |
| No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender … J Defreyne, B Kreukels, G t'Sjoen, A Staphorsius, M Den Heijer, ... Hormones and Behavior 110, 29-39, 2019 | 35 | 2019 |
| Prospective evaluation of self-reported aggression in transgender persons J Defreyne, G T'sjoen, WP Bouman, N Brewin, J Arcelus The journal of sexual medicine 15 (5), 768-776, 2018 | 35 | 2018 |
| Characterisation of testicular function and spermatogenesis in transgender women G Vereecke, J Defreyne, D Van Saen, S Collet, J Van Dorpe, G T'Sjoen, ... Human Reproduction 36 (1), 5-15, 2021 | 32 | 2021 |
| Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during … S Lierman, A Tolpe, I De Croo, S De Gheselle, J Defreyne, M Baetens, ... Fertility and Sterility 116 (4), 1068-1076, 2021 | 30 | 2021 |
| Routine histopathological examination after female-to-male gender-confirming mastectomy SMJ Van Renterghem, J Van Dorpe, SJ Monstrey, J Defreyne, KEY Claes, ... Journal of British Surgery 105 (7), 885-892, 2018 | 29 | 2018 |
| Organizing the voice questionnaire for transgender persons C Bultynck, C Pas, J Defreyne, M Cosyns, G T’Sjoen International Journal of Transgender Health 21 (1), 89-97, 2020 | 28 | 2020 |
| Being Transgender in Belgium: Ten Years Later: 2017 J Motmans, E Wyverkens, J Defreyne Institute for the Equality of Women and Men, 2018 | 23 | 2018 |
